Telehealth in Oncology: ASCO Standards and Practice Recommendations [Jul 28, 2021] Zon et al. JCO Oncology Practice ow.ly/NrAy50HzTZY #telemedicine Robin Zon HT Julie Gralow

Impact of #COVID19 Pandemic on Oncologist Burnout, Emotional Well-Being & Moral Distress: Considerations for the Cancer Organization’s Response for Readiness, Mitigation & Resilience [2/9/21] Fay Hlubocky PhD MA FASCO et al JCO Oncology Practice ow.ly/hcO850DvrSK #CoronaHeroes #COVID19nCancer

Enjoyed working with Texas Society of Clinical Oncology leadership on cancer care strategy for Texas. Great seeing you Dr. Patt and Todd Pickard, MMSc, PA-C, DFAAPA, FASCO

Today the CA “physician misinformation law” went into effect, preventing doctors from sharing the risks associated with mRNA “vaccines” or they can lose their licenses. So I speak for them: any healthy person under 50 who “died suddenly” is mRNA vax until ruled out otherwise

I’m advocating for increasing federal funding for cancer research for NIH, NCI and ARPA-H during the 2023 #ASCOAdvocacySummit. Funding for these agencies remains critical in FY2024, including $ to continue support for the Cancer Moonshot and the National Cancer Plan. 1/4

Thank you to ASCO for organizing the 2023 #ASCOAdvocacySummit We advocated to 1) #FixPriorAuth & protect pt access to care 2) Ensure copay assistance counts towards pt out-of-pocket costs 3) Support fed cancer research National Cancer Institute NIH #nationalcancerplan

At the #ASCOAdvocacySummit with many of the ASCO Delegates to AMA. 1. fix prior authorization 2. Get rid of copay accumulators 3. Fund cancer research

Working together at cancer caucus this am discussing resolutions brought forth by @asco today. Proud of our group- working to influence policy to benefit pts w cancer. #fixpriorauth #biosimilars #clinicaltrials #fixmedicare AMA #AMA23

#AMAmtg #ASCO Team Cancer working on forming policy at AMA annual to bring light to Stark law restrictions affecting private practitioners, biosimilars are not interchangeable, and, as always, improving access to care and decreasing/eliminating disruptions in care due to PAs.

Ray Page, DO PhD presenting the ASCO-supported resolution for ensuring Medicare.gov advantage coverage for routine care costs for pts on clinical trials. Pts first, always. #amamtg #ama23 AMA

Drs Ray Page, DO PhD & Barbara McAneny speaking on behalf of ASCO at AMA #AMAHOD regarding biosimilar therapies for pts w cancer as well as chronic illnesses requiring such therapies. #patientsfirst

Was so excited to be on stage interviewing an All Star team on workforce issues and clinician well being in oncology Todd Pickard, MMSc, PA-C, DFAAPA, FASCO

Very pleased to support my resident, Dr. Joseph Kim, on his poster presentation at TxSCO ⁦Oncology State Societies at ACCC⁩

It was a pleasure to speak on “Individualized Pathways in Oncology Treatment: Not an Oxymoron” at the Clinical Pathways Congress + Cancer Care Business Exchange in Boston

Representing Texas ASCO State Affiliates Council, with Pennsylvania representative, the great Ed Balaban, DO, good friend and years serving together at AMA HOD. Great meeting at ASCO HQ

Hard working ASCO delegation to the AMA. We were 3/3 with adoption of ASCO sponsored resolutions regarding AMA advocacy for access to clinical trials for MEDICARE advantage patients, modernizing remote digital lab access under CLIA, and managing ERISA laws with PBMs

Thank you brother Pete Sessions for catching up today. Always a pleasure. We are asking to: 1️⃣ End shortages of life saving drugs 2️⃣ Support NIH, NCI, & ARPA-H funding 3️⃣ Make telemedicine permanent #ASCOAdvocacySummit

Texas Society of Clinical Oncology ⁦Oncology State Societies at ACCC⁩ was honored to be engaged with Robin Zon MD, FACP, FASCO ⁦Eric J. Small, MD, FASCO⁩ at our annual meeting in San Antonio

The delegation from ASCO had a terrific interim meeting w/ AMA HOD. We made headway on drug shortages, patient access concerns, & other key resolutions. #ASCOadvocacy #advocacy #whywefight

Team Texas is ready for the #ASCOAdvocacySummit! We are asking to prioritize federal research funding, #FixPriorAuth, and help end #drugshortages.